Home›Research›Compare›5-Amino-1MQ vs Sermorelin
Peptide Comparison5-Amino-1MQ vs Sermorelin
5-Amino-1MQ
5-Amino-1-methylquinolinium
49 providers listed
Sermorelin
GHRH 1-29
Half-life: 10–20 minutes
445 providers listed
5-Amino-1MQ and Sermorelin target different goals — 5-Amino-1MQ for fat cell reduction, Sermorelin for pulsatile GH release via direct GHRH receptor agonism at the pituitary. They're compared here for reference, not as direct substitutes.
5-Amino-1MQ
Evidence
Half-life
—
Sermorelin
Evidence
Half-life
10–20 minutes
5-Amino-1MQ and Sermorelin target different goals — 5-Amino-1MQ for Metabolic, Sermorelin for GH / IGF Axis. They're compared here for reference; there isn't a single “better” choice between them.
5-Amino-1MQ
Sermorelin
Sermorelin
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients…
The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostat…
About 5-Amino-1MQ
Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.
About Sermorelin
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on pituitary somatotrophs, stimulating pulsatile GH secretion in a physiological pattern that preserves the natural hypothalamic-pituitary feedback axis — contrasting with direct GH administration. Downstream IGF-1 elevation mediates many of its body composition, tissue-repair, and sleep quality effects.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
5-Amino-1MQ
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Sermorelin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Sermorelin clinical protocols measure IGF-1 as the primary marker of GH axis response. Fasting glucose and insulin are standard baseline assessments given GH's effect on insulin sensitivity.
Sermorelin
Ipamorelin
Research suggests Sermorelin and Ipamorelin may produce complementary growth hormone release effects when combined. Sermorelin acts as a GHRH analogue via pituitary receptors, while Ipamorelin acts via ghrelin receptors — dual-pathway stimulation studied in GH optimization research.
5-Amino-1MQ
Sermorelin
Where to source these peptides
5-Amino-1MQ
49 listed
Browse directory →
Providers offeringSermorelin
445 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 27, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). 5-Amino-1MQ vs Sermorelin — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/5-amino-1mq/sermorelin